Resisting resistance: Maximizing the durability of antiretroviral therapy

Annals of Internal Medicine

Volumn 128, Issue 11, 1998, Pages 951-954

  Condra, J H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; DRUG EFFICACY; DRUG POTENCY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; PRIORITY JOURNAL; TREATMENT FAILURE; VIRUS INHIBITION; VIRUS MUTATION;

EID: 0032102236     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-11-199806010-00017     Document Type: Editorial

References (20)